Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial

PURPOSE: Patients with metastasized breast cancer often suffer from discomfort caused by metastatic bone disease. Thus, osteoprotection is an important part of therapy in breast cancer metastasized to bone, and bisphosphonates (BPs) are a major therapeutic option. In this study, our objectives were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: von Au, Alexandra, Milloth, Eva, Diel, Ingo, Stefanovic, Stefan, Hennigs, Andre, Wallwiener, Markus, Heil, Joerg, Golatta, Michael, Rom, Joachim, Sohn, Christof, Schneeweiss, Andreas, Schuetz, Florian, Domschke, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944913/
https://ncbi.nlm.nih.gov/pubmed/27468239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S103130
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados